Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axsome Thera
(NQ:
AXSM
)
76.21
-1.14 (-1.47%)
Streaming Delayed Price
Updated: 10:56 AM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Axsome Thera
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 19, 2022
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with...
Via
Benzinga
Peering Into Axsome Therapeutics Inc's Recent Short Interest
March 30, 2022
Axsome Therapeutics Inc's (NASDAQ:AXSM) short percent of float has risen 15.16% since its last report. The company recently reported that it has 4.42 million shares sold short,...
Via
Benzinga
Why Axsome Therapeutics Stock Is Trading Higher
March 28, 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ).
Via
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio
March 28, 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) has
Via
Benzinga
Best Biotech Stocks To Buy In 2022
March 15, 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...
Via
Talk Markets
Axsome Therapeutics: Q4 Earnings Insights
March 01, 2022
Axsome Therapeutics (NASDAQ:AXSM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 07, 2022
Gainers Agile Therapeutics (NASDAQ:AGRX) ...
Via
Benzinga
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics
February 02, 2022
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
Gainers ContraFect (NASDAQ:CFRX) stock mo...
Via
Benzinga
2 Top Biotech Stocks Ready for a Bull Run
November 24, 2021
Both of these companies have potential catalysts on the way.
Via
The Motley Fool
Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript
November 08, 2021
AXSM earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Axsome Therapeutics Stock Is Rising Today
November 08, 2021
The company provided its third-quarter update.
Via
The Motley Fool
2 Biotech Stocks Poised for Jaw-Dropping Growth
October 17, 2021
These two tiny drugmakers could make early shareholders wealthy.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Why Axsome Therapeutics Stock Rocketed Higher This Week
October 15, 2021
Optimism among investors is growing for the possible approval of the biotech's MDD drug.
Via
The Motley Fool
1 Beaten-Down Stock With 10X Potential
October 14, 2021
This biotech is down, but it isn't out just yet.
Via
The Motley Fool
45 Biggest Movers From Yesterday
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
Why Axsome Therapeutics Stock Caught Fire in September
October 06, 2021
This beaten-down biotech regained some lost ground last month.
Via
The Motley Fool
Why Wall Street Thinks This Biotech Stock Can Triple Your Money
September 23, 2021
The risks are huge, but so are the potential returns.
Via
The Motley Fool
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
September 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
Why Axsome Therapeutics Stock Cratered in August
September 08, 2021
An unexpected regulatory setback weighed heavily on the biotech's shares last month.
Via
The Motley Fool
3 Healthcare Stocks That Might Skyrocket When COVID Is Over
September 07, 2021
Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over?
Via
The Motley Fool
Exposures
COVID-19
Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?
September 05, 2021
There are still plenty of unknowns related to Axsome's FDA filing.
Via
The Motley Fool
Exposures
Product Safety
3 Biotech Stocks That Are Too Cheap to Ignore
September 02, 2021
You'll definitely want to check out these biotech bargains.
Via
The Motley Fool
Here's Why Axsome Therapeutics Stock Is Surging Today
September 01, 2021
The company still doesn't have much to say about the FDA and its experimental new anti-depression drug.
Via
The Motley Fool
Exposures
Product Safety
10 Biggest Price Target Changes For Monday
August 30, 2021
Barclays raised Affirm Holdings, Inc. (NASDAQ:AFRM
Via
Benzinga
Which Biotech Stock Will Shock the Market in 2022?
August 27, 2021
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.